Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
A large number of cannabinoids have been discovered that could play a role in mitigating cardiac affections. However, none of them has been as widely studied as cannabidiol (CBD), most likely because, individually, the others offer only partial effects or can activate potential harmful pathways. In...
Main Authors: | J. A. Garza-Cervantes, M. Ramos-González, O. Lozano, C. Jerjes-Sánchez, G. García-Rivas |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2020/4587024 |
Similar Items
-
The Possible Pathological Role of Endogenous Cannabinoid System in Heart Failure Syndrome
by: Katerenchuk O.
Published: (2013-03-01) -
Update in cardiomyopathies and congestive heart failure
by: The Heart Hospital, London, UK and Monaldi Hospital, Naples, Italy
Published: (2012-05-01) -
CHRONIC HEART FAILURE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2011-04-01) -
Modifications of Titin Contribute to the Progression of Cardiomyopathy and Represent a Therapeutic Target for Treatment of Heart Failure
by: Charles Tharp, et al.
Published: (2020-08-01) -
Pathogenesis and treatment of heart failure in dilated cardiomyopathy
by: M. A. Gurevich
Published: (2005-02-01)